| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-02-05 FY |
|---|---|---|---|---|---|---|
| Revenue | $3.29B | $3.06B | $2.59B | $1.41B | $770.33M | $77.48M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $133.15M | $140.50M | $128.41M | $82.18M | $62.48M | $5.73M |
| Operating Income | $415.55M | $603.98M | $574.71M | $228.77M | $60.83M | $1.43M |
| Interest Expense | – | – | $59.14M | $42.72M | $31.73M | $229.00K |
| Tax Expense | $56.38M | $43.98M | $30.34M | $22.55M | $365.00K | $3.42M |
| Net Income | $216.72M | $448.35M | $481.90M | $168.95M | $101.98M | $250.23M |
| EPS (basic) | 1.3600 | 3.0100 | 3.4800 | 1.9900 | 1.6100 | 1.0000 |
| EPS (diluted) | 1.3500 | 2.9600 | 3.3200 | 1.7300 | 1.5100 | 0.9800 |
| Shares (diluted) | $160.20M | $151.64M | $145.20M | $97.61M | $67.63M | $256.57M |